StockNews.com lowered shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) from a buy rating to a hold rating in a research report released on Sunday morning. RedHill Biopharma Stock Performance Shares of NASDAQ:RDHL opened at $1.24 on Friday. The business has a fifty day moving average price of $1.90 and a two-hundred day moving average […]
StockNews.com upgraded shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) from a hold rating to a buy rating in a research report report published on Saturday. RedHill Biopharma Stock Down 0.8 % Shares of RDHL stock opened at $1.19 on Friday. RedHill Biopharma has a 12 month low of $1.16 and a 12 month high […]
RedHill Biopharma (NASDAQ:RDHL – Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Saturday. RedHill Biopharma Stock Performance NASDAQ:RDHL opened at $1.20 on Friday. The stock’s fifty day moving average is $2.06 and its two-hundred day moving average is $5.07. RedHill […]
RedHill Biopharma Ltd. (NASDAQ:RDHL – Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 28,200 shares, a decline of 64.5% from the May 31st total of 79,400 shares. Based on an average daily volume of 91,700 shares, the […]
RedHill Biopharma (NASDAQ:RDHL – Get Rating) and vTv Therapeutics (NASDAQ:VTVT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk. Analyst Recommendations This is a breakdown of current ratings […]